With a background as a Patent Examiner and Biomedical Engineer, I offer extensive expertise in Gene Therapy, STEM Cell Research, and Immunotherapy (CAR-T), as well as targeted drug delivery and biosensing technology. My leadership has secured funding for Phase 2 SBIR projects totaling nearly $1 million from prestigious entities like the NIH, NSF, and DoD. I excel in managing complex biopharmaceutical projects, demonstrating drive, leadership, and collaborative efficiency.
Deadline Management
23, 2, and 48